Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents - PubMed (original) (raw)

. 2000 Jul 28;275(30):23199-203.

doi: 10.1074/jbc.M002674200.

Affiliations

• PMID: 10930428
• DOI: 10.1074/jbc.M002674200

Free article

Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents

Y Higashimoto et al. J Biol Chem. 2000.

Free article

Abstract

To characterize the sites in human p53 that become phosphorylated in response to DNA damage, we have developed polyclonal antibodies that recognize p53 only when it is phosphorylated at specific sites. Several attempts to generate an antibody to p53 phosphorylated at Ser(6) using a phosphoserine-containing peptide as an immunogen were unsuccessful; however, phosphorylation-specific antibodies were produced by using the phosphoserine mimetic, l-2-amino-4-phosphono-4, 4-difluorobutanoic acid (F(2)Pab), in place of phosphoserine. Fmoc-F(2)Pab was prepared by an improved synthesis and chemically incorporated using solid phase peptide synthesis. Affinity-purified antibodies elicited by immunizing rabbits with an F(2)Pab peptide coupled to keyhole limpet hemocyanin recognized a p53(1-39) peptide phosphorylated only at Ser(6) but not the unphosphorylated peptide or the same peptide phosphorylated at Ser(9), Ser(15), Ser(20), Ser(33), or Ser(37). Untreated A549 cells exhibited a background of constitutive phosphorylation at Ser(6) that increased approximately 10-fold upon exposure to either ionizing radiation or UV light. Similar results were obtained for Ser(9) using antibodies raised against a conventional phosphopeptide. Ser(9) was phosphorylated by casein kinase 1 in vitro in a phosphoserine 6-dependent manner. Our data identify two additional DNA damage-induced phosphorylations in human p53 and show that F(2)Pab-derivatized peptides can be used to develop phosphorylation site-specific polyclonal antibodies.

PubMed Disclaimer

Similar articles

• Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage.
  Chao C, Saito S, Anderson CW, Appella E, Xu Y. Chao C, et al. Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11936-41. doi: 10.1073/pnas.220252297. Proc Natl Acad Sci U S A. 2000. PMID: 11035798 Free PMC article.
• DNA damage induces phosphorylation of the amino terminus of p53.
  Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB. Siliciano JD, et al. Genes Dev. 1997 Dec 15;11(24):3471-81. doi: 10.1101/gad.11.24.3471. Genes Dev. 1997. PMID: 9407038 Free PMC article.
• Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389.
  Lu H, Taya Y, Ikeda M, Levine AJ. Lu H, et al. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6399-402. doi: 10.1073/pnas.95.11.6399. Proc Natl Acad Sci U S A. 1998. PMID: 9600977 Free PMC article.
• Signaling to p53: breaking the posttranslational modification code.
  Appella E, Anderson CW. Appella E, et al. Pathol Biol (Paris). 2000 Apr;48(3):227-45. Pathol Biol (Paris). 2000. PMID: 10858956 Review.
• The alpha,alpha-difluorinated phosphonate L-pSer-analogue: an accessible chemical tool for studying kinase-dependent signal transduction.
  Panigrahi K, Eggen M, Maeng JH, Shen Q, Berkowitz DB. Panigrahi K, et al. Chem Biol. 2009 Sep 25;16(9):928-36. doi: 10.1016/j.chembiol.2009.08.008. Chem Biol. 2009. PMID: 19778720 Free PMC article. Review.

Cited by

• Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition.
  Hassel JC, Zimmer L, Sickmann T, Eigentler TK, Meier F, Mohr P, Pukrop T, Roesch A, Vordermark D, Wendl C, Gutzmer R. Hassel JC, et al. Cancers (Basel). 2023 Jun 30;15(13):3448. doi: 10.3390/cancers15133448. Cancers (Basel). 2023. PMID: 37444558 Free PMC article. Review.
• p53-Dependent Cytoprotective Mechanisms behind Resistance to Chemo-Radiotherapeutic Agents Used in Cancer Treatment.
  Krishnaraj J, Yamamoto T, Ohki R. Krishnaraj J, et al. Cancers (Basel). 2023 Jun 28;15(13):3399. doi: 10.3390/cancers15133399. Cancers (Basel). 2023. PMID: 37444509 Free PMC article. Review.
• Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53.
  Marques MA, de Andrade GC, Silva JL, de Oliveira GAP. Marques MA, et al. Front Mol Biosci. 2022 Aug 25;9:944955. doi: 10.3389/fmolb.2022.944955. eCollection 2022. Front Mol Biosci. 2022. PMID: 36090037 Free PMC article. Review.
• PermaPhos Ser : autonomous synthesis of functional, permanently phosphorylated proteins.
  Zhu P, Franklin R, Vogel A, Stanisheuski S, Reardon P, Sluchanko NN, Beckman JS, Karplus PA, Mehl RA, Cooley RB. Zhu P, et al. bioRxiv [Preprint]. 2021 Dec 14:2021.10.22.465468. doi: 10.1101/2021.10.22.465468. bioRxiv. 2021. PMID: 34931187 Free PMC article. Updated. Preprint.
• Regulating tumor suppressor genes: post-translational modifications.
  Chen L, Liu S, Tao Y. Chen L, et al. Signal Transduct Target Ther. 2020 Jun 10;5(1):90. doi: 10.1038/s41392-020-0196-9. Signal Transduct Target Ther. 2020. PMID: 32532965 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal